thus by observing the effect of addition of cyclosporin a , monoclonal anti-hla-dr antibody , and recombinant interleukin 2 ( ril-2 ) on the spontaneous proliferation of sfmc from patients with rheumatoid arthritis ( ra ) and a wide range of seronegative spondyloarthritides ( sn ) , we have demonstrated that this phenomenon is : ( i ) a t cell response , ( ii ) inhibited by the addition of cyclosporin a or monoclonal anti-hla-dr antibody , ( iii ) enhanced by the addition of ril-2 and ( iv ) the ril-2 enhancement of the spontaneous proliferation is inhibited by a monoclonal anti-hla-dr antibody .
C0003873
rheumatoid arthritis
C0010592
cyclosporin a